Skip to Main Content

Author Details

Dongquan Chen
University of Alabama at Birmingham
1997
94
34
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37380890Ribosome biosynthesis and Hedgehog activity are cooperative actionable signaling mechanisms in breast cancer following radiotherapy.NPJ Precis Oncol2023
37380890Ribosome biosynthesis and Hedgehog activity are cooperative actionable signaling mechanisms in breast cancer following radiotherapy.NPJ Precis Oncol2023
37058110Hedgehog Signaling Regulates Treg to Th17 Conversion Through Metabolic Rewiring in Breast Cancer.Cancer Immunol Res2023
37058110Hedgehog Signaling Regulates Treg to Th17 Conversion Through Metabolic Rewiring in Breast Cancer.Cancer Immunol Res2023
35180388Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition.Cell2022
35907952Hedgehog blockade remodels the gut microbiota and the intestinal effector CD8<sup>+</sup> T cells in a mouse model of mammary carcinoma.Lab Invest2022
35180388Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition.Cell2022
35907952Hedgehog blockade remodels the gut microbiota and the intestinal effector CD8<sup>+</sup> T cells in a mouse model of mammary carcinoma.Lab Invest2022
33410252Merlin deficiency alters the redox management program in breast cancer.Mol Oncol2021
34078871Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors.Oncogenesis2021
34289986Hedgehog Signaling Regulates Metabolism and Polarization of Mammary Tumor-Associated Macrophages.Cancer Res2021
33946684Associations between DNA Damage and PD-L1 Expression in Ovarian Cancer, a Potential Biomarker for Clinical Response.Biology (Basel)2021
33664239Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer.Cell Death Dis2021
33663560An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.Breast Cancer Res2021
34326467Nuclear Aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: implications for detection of metastatic tumors.Oncogene2021
34298684The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer.Cancers (Basel)2021
33410252Merlin deficiency alters the redox management program in breast cancer.Mol Oncol2021
34787469Erratum for Cumming et al., "Host Bioenergetic Parameters Reveal Cytotoxicity of Antituberculosis Drugs Undetected Using Conventional Viability Assays".Antimicrob Agents Chemother2021
33664239Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer.Cell Death Dis2021
33663560An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.Breast Cancer Res2021
34787469Erratum for Cumming et al., "Host Bioenergetic Parameters Reveal Cytotoxicity of Antituberculosis Drugs Undetected Using Conventional Viability Assays".Antimicrob Agents Chemother2021
34078871Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors.Oncogenesis2021
34326467Nuclear Aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: implications for detection of metastatic tumors.Oncogene2021
34298684The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer.Cancers (Basel)2021
34289986Hedgehog Signaling Regulates Metabolism and Polarization of Mammary Tumor-Associated Macrophages.Cancer Res2021
33946684Associations between DNA Damage and PD-L1 Expression in Ovarian Cancer, a Potential Biomarker for Clinical Response.Biology (Basel)2021
32508817Contrasting Inflammatory Signatures in Peripheral Blood and Bronchoalveolar Cells Reveal Compartment-Specific Effects of HIV Infection.Front Immunol2020
32039707Correction to: Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection.BMC Infect Dis2020
33044225Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.J Clin Invest2020
32870163Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.J Clin Invest2020
33127760CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.Proc Natl Acad Sci U S A2020
32508817Contrasting Inflammatory Signatures in Peripheral Blood and Bronchoalveolar Cells Reveal Compartment-Specific Effects of HIV Infection.Front Immunol2020
32894284Hedgehog signaling enables repair of ribosomal DNA double-strand breaks.Nucleic Acids Res2020
32039707Correction to: Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection.BMC Infect Dis2020
33127760CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.Proc Natl Acad Sci U S A2020
33044225Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.J Clin Invest2020
32870163Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.J Clin Invest2020
32894284Hedgehog signaling enables repair of ribosomal DNA double-strand breaks.Nucleic Acids Res2020
30759398Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.Cell Rep2019
31822287Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection.BMC Infect Dis2019
30759398Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.Cell Rep2019
30808975MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer.Oncogene2019
31822287Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection.BMC Infect Dis2019
30808975MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer.Oncogene2019
28753783Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets.Eur Urol Focus2018
28753783Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets.Eur Urol Focus2018
29878111Discovery, fine-mapping, and conditional analyses of genetic variants associated with C-reactive protein in multiethnic populations using the Metabochip in the Population Architecture using Genomics and Epidemiology (PAGE) study.Hum Mol Genet2018
29869736Composition and richness of the serum microbiome differ by age and link to systemic inflammation.Geroscience2018
30224769Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.Sci Rep2018
29937354Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.Cancer Cell2018
  • 1 - 50 of 188

Recommended Authors

Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
University of California irvine
Career Start Year 2009
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
College of Bioinformatics Science and Technology, Harbin Medical University
Career Start Year 2007
Number of shared co-authors 0
Urumqi Friendship Hospital
Career Start Year 2005
Number of shared co-authors 1
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 0
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 1
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 1
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 0
Ningbo First Hospital, Zhejiang University
Career Start Year 2000
Number of shared co-authors 1
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
John A. Burns School of Medicine, University of Hawaii at Manoa
Career Start Year 1999
Number of shared co-authors 1
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 0
Uniformed Services University of the Health Sciences
Career Start Year 1997
Number of shared co-authors 1
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 5
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year 1989
Number of shared co-authors 1
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 3

Collaborators

University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Co-authored papers 6
University of Alabama at Birmingham
Co-authored papers 5
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 5
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 5
University of Alabama at Birmingham
Co-authored papers 3
University of Alabama at Birmingham
Co-authored papers 3
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 2
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 2
HudsonAlpha Institute for Biotechnology
Co-authored papers 2
School of Public Health, University of Alabama at Birmingham
Co-authored papers 2
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Co-authored papers 2
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
The University of Alabama School of Medicine
Co-authored papers 2
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 1
University of Windsor
Co-authored papers 1
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
University of Virginia
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
University of Alabama at Birmingham Birmingham
Co-authored papers 1